New to the Region Spotlight: Sanborn, Head & Associates

Commentator: Michael Nicoloro, Senior Vice President, Sanborn, Head & Associates

Tell us about Sanborn, Head & Associates.

Sanborn, Head & Associates (Sanborn Head) was founded in New England in 1993 as an engineering consulting firm that applied its technical expertise to help clients solve geotechnical and environmental engineering challenges that are associated with urban development, active industrial and manufacturing facilities, and solid waste facilities such as landfills.

Over the past ten years, Sanborn Head has developed an Energy Practice that has quickly been established as a leader in the natural gas infrastructure design space, particularly due to our expertise with liquefied natural gas (LNG) and compressed natural gas (CNG) engineering design services.

Where is your new office located?

We are located on 100 North 18th Street, Suite 300, Philadelphia, PA 19103. This is a springboard location as we build out our team with the goal of settling on a permanent location in Philadelphia.

How many employees are located there?

We are targeting an office size of 10 employees within a three-year window. Our intention is to serve local clients by providing the full range of services we offer.

What drove your decision to expand in Greater Philadelphia?

Philadelphia emerged as an attractive market given the mix of energy and environmental services, we have expertise in. With its robust industrial and manufacturing past, location at the confluence of many exciting energy-related developments, such as the Marcellus Shale natural gas formation, and relative proximity to other major markets within the Northeast Corridor, it was an opportunity we couldn’t pass up.

As a first step, Sanborn Head engaged the Chamber of Commerce for Greater Philadelphia as a partner for this expansion and quickly found it to be a fruitful strategic relationship, particularly through our involvement in the Greater Philadelphia Energy Action Team (GPEAT). Though all our services have found a niche for expansion in the region, the primary driver of this expansion has been our specialized LNG and CNG engineering practice.

If there is one thing that the local business community can do to help ensure your continued success in this market, what would that be?

Support natural gas initiatives. It’s a need not a want. Without it as part of our energy portfolio, society will be subjected to a quality of life that is less than what we have today.



Check out a recent episode of Growing Greater featuring Mike Nicoloro of Sanborn Head & Associates. Mike explains what makes the energy landscape in this region unique and where the future of energy is heading.


Michael Nicoloro, Senior Vice President, Sanborn, Head & Associates
[email protected]
(617) 605-4839

New Development Coming to uCity Square

Development for One uCity Square officially broke ground in late January and is expected to finish by the end of 2021. The University City Science Center, Ventas Inc., and Wexford Science and Technology have partnered to create the $280 million, 400,000-square-foot building.

Developers fully expect that the new building will be in high demand once completed.

“We feel very bullish on the market and our ability to fill this building,” said Joseph Reagan Jr., senior vice president of Wexford Science and Technology. “We didn’t want to have a situation where we have demand and no place to put people.”

One uCity Square will have lab and office space, ground-floor retail, a full-service restaurant, a lobby, and gathering spaces with rent close to or exceeding $50 per square foot. A new 45,000-square-foot public park will also be adjacent to the uCity Square building and a new 460-unit apartment building will be nearby.

In October of 2019, Genetic Engineering & Biotechnology News listed Greater Philadelphia on the top 10 biotech hubs throughout the country. The ranking was based on multiple factors including the One uCity Square building that is expected to attract more life sciences companies to our region.

The Region’s Life Sciences Sector Continues to Expand

The Discovery Labs announced a massive addition to its 1.6 million-square-foot life sciences campus in King of Prussia, PA. The company will build a $1.1 billion, 680,000-square-foot development and manufacturing facility as a part of a joint venture with New York-based Deerfield Management.

The addition to The Discovery Labs campus will be known as the Center for Breakthrough Medicines, making The Discovery Labs the largest contract development and manufacturing organization in the world.

This development comes from the understanding that the cell and gene therapy companies expanding in Greater Philadelphia need more manufacturing capabilities to grow.

“What’s great about the King of Prussia location and the region, not just from the perspective of talent, is we’re very close to Europe on the East Coast,” Discovery Labs Executive Managing Director Audrey Greenberg said. “So we’ll be able to supply viral vectors and plasmids to much of the U.S., Europe and possibly even Asia Pacific, South America, and the Middle East.”

After the addition is completed, The Discovery Labs is expected to employ 2,000 people.

Listen to a recent Growing Greater podcast featuring entrepreneur and real estate developer Brian O’Neill who is re-imaging the space The Discovery Labs is located on as a fully integrated environment for Big Pharma, emerging biotech start-ups, high tech companies, venture capitalists, and more to cohabitate under one roof.

Rowan University Awarded for Use of New Technologies

An international technology and marketing company, IDG, honored Rowan University with a 2020 FutureEdge 50 Award for the university’s use of new technologies. In recent years, Rowan transformed its data analytics program to be accessible and usable by employees at all levels.

Rowan’s data analytics program, led by the Division of Information Resources & Technology (IRT), has effectively and efficiently attracted and retained students. IRT has been successful in doing so through its partnership with the Division of Student Affairs to create models that predicted student enrollment at the university.

“The FutureEdge 50 Award recognizes my team’s exceptional work in developing tools that allow for meaningful and timely data analysis throughout Rowan University,” said Dr. Mira Lalovic-Hand, Senior VP of IRT and Chief Information Officer. “These tools, techniques, and methodologies have helped drive increases in applications, enrollment, and student body diversity.”

The FutureEdge 50 Award is presented by IDG’s CIO Executive Council and recognizes organizations that are innovating new technologies to advance their business for the future.

In December, Rowan was awarded a $100,000 grant by the New Jersey State Board of Public Utilities to study expanding electric vehicle (EV) infrastructure in local underserved communities. Rowan continues to lead initiatives that grow our region’s innovation economy.

The Reimagining of an Opportunity Zone in Wilmington, Delaware

Washington Place Equities of Baltimore has announced plans to build apartments in South Wilmington, Delaware. This $32 million development project will be the first of its type in years for the Southbridge neighborhood.

By mid-2021, the developer expects to have 150-units open and 300 more units shortly after.

The Vice President of Washington Place Equities, Dominic Wiker said the area will appeal to “people looking for a different type of location.” The property, which is in an opportunity zone, is close to the city’s train station, to the river’s edge, and to what will be the area’s newest park.

Wiker and his company were interested in this location because he foresees growth in Wilmington and cities in southcentral Pennsylvania, which he referred to as “middle-market-cities.”

Development projects continue to pop up in Wilmington, Delaware throughout the years. In February of 2018, Wilmington’s historic Hotel DuPont received $400,000 in renovations in an effort to attract more travelers to the region.

Listen to S2 E43: The World is Watching with ESM Productions

Listen to our Growing Greater podcast episode with Scott Mirkins, President and Executive Producer of ESM Productions, a Roc Nation company.

In this episode, Scott explains just how he got involved with live events from an early age and how he executed programs such as the World Meeting of Families with Pope Francis and Jay-Z’s “Made in America” Festival featuring Beyoncé and Post Malone.

Catch up on previous episodes of Growing Greater to hear engaging stories of economic development, innovation, health care, and more from industry leaders. We encourage you to subscribe, share, and rate Growing Greater in your favorite podcast app.

Photo from Visit Philadelphia

Delaware Innovation Space Doubles Startup Funding

Delaware Innovation Space (DIS) is now doubling down on funding for startups in its First Fund investment program. Startups are able to receive $150,000 in funding–$75,000 awarded in cash and $75,000 awarded in DIS services.

The First Fund investment program launched in March 2019 by DIS in an effort for early-stage science startups to gain access to IRL and DIS resources, such as a wet lab space with lab pods, equipment, and incubation for businesses.

DIS is a startup accelerator created in a partnership among DuPont, the University of Delaware, and the State of Delaware. Many companies have been involved in the DIS acceleration, including Prelude Therapeutics, Incyte, Napigen, and W7Energy.

Last April, DIS received $3 million from the National Development Council to continue transforming science-focused startups into leading companies. Since DIS’s evolution in 2017, the acceleration has created many opportunities for entrepreneurs and taken part in job growth throughout the state.

Camden, NJ Continues to Lead Towards Major Economic Growth

Cooper University Health Care (Cooper) has bought a five-story, 102,000-square-foot building in Camden, NJ for $16 million.

According to a Cooper spokesperson, Wendy Marano, this purchase gives Cooper the “opportunity to meet the growing demand for its services.”

Camden County has been seeking a new use for the building that would create more jobs and build economic growth. “This is another piece of the continued growth and expansion to the ever-evolving eds and meds corridor in Camden City creating another revitalized asset for prime office space in the downtown,” said Camden County spokesman, Dan Keashen.

Camden was referred to as an “Eds and Meds” corridor after the opening of a new health care center in November of 2019. The center is in partnership with Rowan University, Rutgers-Camden, Cooper Medical School of Rowan University, and Camden County College, and is expected to drive future job growth and economic activity in Camden.

Thomas Jefferson University Will Create Over 250 Jobs

Philadelphia-based Thomas Jefferson University (Jefferson) received its second largest donation at $70 million. The gift was from Sidney and Caroline Kimmel and will be used to expand the biomedical research at its Center City location.

The expansion includes a 12-story building, which will be named the Caroline Kimmel Biomedical Research Building and will cost nearly $350 million.

“This new building will be 225,000-square-feet, all devoted to research,” Dr. Stephen Klasko, President of Thomas Jefferson University and CEO of Jefferson Health, told the Philadelphia Business Journal.

This new building is expected to create 250 to 400 new jobs at Jefferson.

“The Caroline Kimmel Biomedical Research Building will serve as a magnet for scientific talent and will bolster our status as a national research university,” said Dr. Mark Tykocinski, Provost and Executive Vice President, Thomas Jefferson University, and Dean of Sidney Kimmel Medical College at Thomas Jefferson University.

In June of 2019, Jefferson opened their new $7 million Jefferson Institute for Bioprocessing facility located in Montgomery County. Jefferson continues to add to our region’s top-notch health care sector.

Pinpoint Therapeutics Identified New Cancer Treatment Using CRISPR

The University of Pennsylvania spinout, Pinpoint Therapeutics, raised $1 million to continue to research and develop cancer treatments.

Pinpoint Therapeutics was founded in 2018 by researchers, Ravi Amaravadi and Jeffrey D. Winkler, from Penn’s Abramson Cancer Center who are commercializing their technology to create new cancer treatments.

Researchers use Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing technology to show that removing PPT1, an enzyme identified by Abramson researchers, has slowed tumor growth. CRISPR allows researchers to alter DNA and modify gene function.

“The edited cells look like they’ve been treated with a drug, and they grow significantly slower than the unedited cells,” Amaravadi said when discussing study results last year.

Pinpoint Therapeutics currently operates at the Pennovation Center and is led by Christian Peters, the President and CEO.

It was nearly eight months ago that CRISPR was approved by the FDA as a cancer treatment at the University of Pennsylvania. The gene editing technique has continued to make major breakthroughs in the health care industry.